Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Altasciences announced that construction work has begun on the expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services.
read more
Altasciences have entered into an agreement with Amador Bioscience, a translational and consulting clinical research organization located in China and the U.S.
read more
ALTEN Calsoft Labs has launched – "BioPharma Ledger," a Blockchain clinical trial platform.
read more
Tuesday, February 26, 2013
Althea Technologies, Inc., a leading provider of biopharmaceutical development and manufacturing services, and Profectus BioSciences Inc, a technology based vaccine company, today announced the signing of a manufacturing supply agreement for plasmid ...
read more
Tuesday, September 25, 2012
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products, announced today the promotion of Rick Hancock to the position of President and CEO, Chris Duffy to Senior Vice President of ...
read more
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products, announced today the appointment of Dr. Kristin DeFife as Director, Biologics Manufacturing, and Jack Wright as VP, Sales and ...
read more
Althea Technologies, a leading provider of development and manufacturing services for biopharmaceutical products, today announced that Dennis Fenton, Ph.D., will chair Althea’s Scientific Advisory Board and be appointed as Board Observer. Dr. Fenton ...
read more
Wednesday, March 17, 2021
Altimmune has expanded its previously-announced AdCOVID™ manufacturing collaboration with Lonza.
read more
CMC ICOS Biologics, Inc. and Altor BioScience Corporation have entered into a manufacturing agreement for the cGMP manufacturing of Altor’s ALT-803 molecule for use in Phase 3 clinical trials.
read more
SmartCelle is Altus Formulation's proprietary polymeric micellar technology for parenteral, oral and topical delivery of insoluble molecules.
read more
Wednesday, October 24, 2018
Bazelet signed a manufacturing and licensing agreement with Israeli medical cannabis pharmaceutical product developer Alvit LCS Pharma.
read more
Tuesday, October 06, 2015
Alvogen has acquired five hormonal branded products from Bayer Pharma AG in Russia and CIS.
read more
Wednesday, August 26, 2015
Alvogen has entered into a definitive agreement with Pfizer under which it will acquire a portfolio of four pharmaceutical products.
read more
Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions, Inc. („Finesse“), today announce that they have entered into a partnership that will provide Alvotech with world-class, scalable, flexible and cost-efficient ...
read more
Tuesday, December 07, 2021
Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition Corp. II, a special purpose acquisition company ...
read more